Asian Journal of Dairy and Food Research, volume 37 issue 1 (march 2018) : 28-34

Probiotics from food and eubiosis in Gut: a commensalism

Sucheta, Rakesh Gehlot, Simran Arora
1Centre of Food Science and Technology, Chaudhary Charan Singh Haryana Agricultural University, Hisar-125 004, Haryana, India.
Cite article:- Sucheta, Gehlot Rakesh, Arora Simran (2018). Probiotics from food and eubiosis in Gut: a commensalism. Asian Journal of Dairy and Food Research. 37(1): 28-34. doi: 10.18805/ajdfr.DR-1267.
Micro-organisms are not only pathogenic but also commensal to humans and are associated with many tissues. They show commensalism by excluding or inhibiting pathogens in intestine lumen or they can improve gut barrier by inducing mucin secretion, defensin production and enhancing tight junctions stability. They can also improve immune system modulation. This may be due to activation of certain signaling pathways by probiotic bacteria which enhance adaptive immunity. Advances on the knowledge of inter-relationships between strain specificity, molecular basis of mechanism of action, host cell factors including its genetic makeup can help to determine potential benefits derived from intake of probiotic food supplements.
  1. Alakomi HL, Skyttä E, Saarela M, Mattila-Sandholm T, Latva-Kala K., Helander IM, (2000). Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol. 66: 2001–2005.
  2. Antoine JM (2010). Probiotics: beneficial factors of the defence system. Proc. Nutr. Soc. 69: 429–433.
  3. Artis D (2008). Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8: 411–420.
  4. Banerjee P, Merkel GJ, Bhunia AK (2009). Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium diffi cile to Caco-2 cells. Gut Pathog. 1: 1-8.
  5. Binns N (2013). Probiotics, prebiotics and the gut microbiota. ILSI Europe concise monograph series. 1-32.
  6. Caballero-Franco C, Keller K, De Simone C, Chadee K (2007). The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol. 292(1) : G315-322.
  7. Carding S, Verbeke K, Vipond DT, Corfe BM, Owen LJ (2015). Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease. 26 : 26191.
  8. Carey CM, Kostrzynska M, Ojha S, Thompson S (2008). The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J. Microbiol. Methods. 73: 125-132.
  9. Collado MC, Meriluoto J, Salminen S (2007). Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol. 45: 454-460.
  10. Corr SC, Hill C, Gahan CG (2009). Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv Food Nutr Res. 56: 1-15.
  11. Corr SC, Li Y, Riedel CU, Toole PWO, Hill C, Gahan CG (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA. 104 (18): 7617-21.
  12. Cotter PD, Hill C, Ross RP (2005). Bacteriocins:developing innate immunity for food. Nature Rev. Microbiol. 3: 777-788.
  13. Cretenet M, Nouaille S, Thouin J, Rault L, Stenz L, François P, Hennekinne JA, Piot M, et al. (2011). Staphylococcus aureus virulence and metabolism are dramatically affected by Lactococcus lactis in cheese matrix. Environ. Microbiol. Rep. 3: 340-351.
  14. Denkova R, Denkova Z, Yanakieva V, Blazheva D (2013). Antimicrobial activity of probiotic lactobacilli, bifidobacteria and propionic acid bacteria, isolated from different sources. FORMATEX. 857-864.
  15. Even S, Charlier C, Nouaille S, Zakour BenN, Cretenet M, Cousin FJ and Gautier M, et al. (2009). Staphylococcus aureus virulence expression is impaired by Lactococcus lactis in mixed cultures. Appl. Environ. Microbiol. 75: 4459-4472.
  16. Fuller R (1991). Probiotics in human medicine. Gut. 32: 439-442.
  17. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O’Neil DA, Macfarlane GT (2005). Synbiotic therapy initiates resolution of inflammation in patients with active ulcerative colitis: A randomized controlled pilot trial. Gut. 54(2): 242-249.
  18. Gaudier E, Michel C, Segain JP, Cherbut C, Hoebler C (2005) The VSL# 3 probiotic mixturemodifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. J. Nutr. 135: 2753–2761.
  19. Gogineni VK, Morrow LE, Malesker, MA (2013). Probiotics: mechanisms of action and clinical applications. J. Prob. Health. 1: 101.
  20. Gueimonde M, Jalonen L, He F, Hiramtasu M, Salminen S (2006). Adhesion and competitive inhibition and displacement of human enteropathogens by selected lactobacilli. Food Res. Int. 39: 467–471.
  21. Guerrero AC, Hernandez-Sanchez H, Rodriguez-Serrano G, Gomez-Ruiz L, Garcia-Garibay M, Figueroa-Gonzalez I (2013). Commercial probiotic bacteria and probiotic carbohydrates: a fundamental study on prebiotics uptake, antimicrobials production and inhibition of pathogens. J. Sci. Food Agric. 94: 2246-2252.
  22. Haghshenas B, Haghshenas M, .Nami Y, Khosroushahi AY, Abdullah N, Barzegari A, Rosli R, Hejazi MS (2016). Probiotic Assessment of Lactobacillus plantarum 15HN and Enterococcus mundtii 50H Isolated from Traditional Dairies Microbiota. Adv. Pharm. Bull. 6 (1): 37-47.
  23. Halami PM, Badarinath V, Manjulata DeviS, Vijayendra SVN (2011). Partial characterization of heat stable, antilisterial and cell lytic bacteriocins of Pediococcus pentosaceus CFR SIII isolated from a vegetable source. Ann. Microbiol. 61: 323–330.
  24. Hemalatha R, Kumar M, Das N, Kumar NS, Challa HR, Nagpal R (2014). Effect of probiotic Lactobacillus salivarius UBLS22 and probiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J. Cardiovasc. Pharmacol. Ther. 20(3): 289–298.
  25. Hemsworth JC, Hekmat S, Reid G (2012). Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes. 3: 414–419.
  26. Hernandez-Mendoza A, Gonzalez-Cordova AF, Vallejo-Cordoba B, Garcia HS (2011). Effect of oral supplementation of Lactobacillus reuteri in reduction of intestinal absorption of afl atoxin B(1) in rats. J. Basic Microbiol. 51: 263-268.
  27. Juntunen M, Kirjavaine PV, Ouwehand AC, Salminen SJ, Isolauri E (2001). Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 8(2): 293-296.
  28. Kailasapathy K, Harmstorf I, Phillips M (2008). Survival of Lactobacillus acidophilus and Bifidobacterium animalis ssp. lactis in stirred fruit yogurts. LWT- Food Sci. Technol. 41(7): 1317-1322.
  29. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brommer RJ, Wells JM (2010). Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 298 (6): G851-9.
  30. Khan I, Kang C (2016). Probiotic potential of nutritionally improved Lactobacillus plantarum DGK-17 isolated from kimchi- a traditional Korean fermented food. Food Control. 60: 88-94.
  31. Kollath W (1953). Nutrition and the tooth system; general review with special reference to vitamins. Dtsch Zahnärztl. Z 8: 7–16.
  32. Kolling GL, Wu M, Alcantara-Warren C, Durmaz E, Klaenhammer TR, Guerrant RL (2012). Lactic acid production by Streptococcus thermophilus alters Clostridium diffi cile infection and in vitro Toxin A production. Gut Microbes. 3(6): 523-539.
  33. Kumar BV, Vijayendra SVN, Reddy OVS (2015). Trends in dairy and non-dairy products-a review. J. Food Sci. Technol. 52(10): 6112-6124.
  34. Laughton JM, Devillard E, Heinrichs DE, Reid G, McCormick JK (2006). Inhibition of expression of a staphylococcal superantigen-    like protein by a soluble factor from Lactobacillus reuteri. Microbiol. 152(4): 1155-67.
  35. Lebeer S, Vanderleyden J, Keersmaecker SCJD (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature Rev. Microbiol. 8: 171-184.
  36. Liévin-Le MV, Servin AL (2006). The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 19: 315–337.
  37. Li J, Wang W, Xu SX, Magarvey NA, McCormick JK (2011). Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. USA. 108: 3360–3365.
  38. Lilly DM, Stillwell RH (1965). Probiotics: growth-promoting factors produced by microorganisms. Science. 147: 747–748.
  39. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R (2012). Diversity, stability and resilience of the human gut microbiota. Nature. 489: 220-230.
  40. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA (2003). Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 52: 827-833.
  41. Makras L, Triantafyllou V, Fayol-Messaoudi D, Adriany T, Zoumpopoulou G, Tsakalidou E (2006). Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. Res Microbiol. 157:241–7.
  42. Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG (2002). Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr. Surg. Int. 18: 586–590.
  43. McGuckin MA, Linden SK, Sutton P, Florin, TH (2011). Mucin dynamics and enteric pathogens. Nature Rev. Microbiol. 9: 265-278.
  44. Mondel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, Fellermann K, Stange EF, Wehkamp J (2009). Probiotic Escherichia coli treatment mediates antimicrobial human betadefensin synthesis and fecal excretion in humans. Mucosal Immunol. 2: 166–172.
  45. Ogawa M, Shimizu K, Nomoto K, Takahashi M, Watanuki M, Tanaka R, Tanaka T, et al.(2001). Protective effect of Lactobacillus casei strain Shirota on Shiga toxinproducing Escherichia coli O157:H7 infection in infant rabbits. Infect. Immun. 69: 1101–1108.
  46. Ohland CL, MacNaughton WK (2010). Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 298: 807-819.
  47. Pessione E (2014). Interactive Probiotics. CRC Press, Taylor and Francis Group, USA. Ed 1st. 
  48. Peterson JW (1996). Bacterial pathogenesis In: Medical Microbiology. Galveston (TX): University of Texas Medical Branch at Galveston. Chapter 7. Ed 4th.
  49. Pithva S, Ambalam P, Dave JM, Vyas BRM (2011). Antimicrobial peptides of probiotic Lactobacillus strains. FORMATEX. 2011, 987-991.
  50. Prado FC, Parada JL, Pandey A, Soccol CR (2008). Trends in non-dairy probiotic beverages. Food Res. Int. 41: 111–123.
  51. Preedy VR, Watson RR (2016). Probiotic, probiotic and synbiotics: Bioactive Foods in Health Promotion. Elsevier UK. pp: 908.
  52. Qin HL, Shen, TY, Gao, ZG (2005). Effect of lactobacillus on gut microflora and barrier function of the rats with abdominal infection. World J. Gastroenterol. 11: 2591-2596.
  53. Rao RK, Samak G (2013). Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr. Nutr. Food Sci. 9(2): 99-107.
  54. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P (2001). Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2(4): 361-367.
  55. Ren D, Li C, Qin Y, Yin R, Li X, Tian M, Du S, Guo H, Liu C, Zhu N, Sun D, Li Y, Jin N (2012). Inhibition of Staphylococcus aureus adherence to Caco-2 cells by lactobacilli and cell surface properties that influence attachment. Anaerobe. 18:508-515.
  56. Rivera-Espinoza Y, Gallardo-Navarro Y (2010). Non-dairy probiotic products. Food Microbiol. 27: 1–11.
  57. Saad N, Delattre C, Urdaci M, Schmitter JM, Bressollier P (2013). An overview of the last advances in probiotic and prebiotic field. LWT-Food Sci. Technol. 50: 1–16.
  58. Sanders ME (2009). How do we know when something called “Probiotic” is really a probiotic? A guideline for consumers and health care professionals. Funct. Food Rev. 1: 3-12.
  59. Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann K (2008). Probiotic lactobacilli and VSL#3 induce enterocyte betadefensin-    2. Clin. Exp. Immunol. 151: 528–535.
  60. Suskovic J, Kos B, Beganovic J, Pavunc AL, Habjanic K, Matosic S (2010). Antimicrobial Activity-The Most Important Property of Probiotic and Starter Lactic Acid Bacteria. Food Technol. Biotechnol. 48(3): 296-307.
  61. Tassell MLV, Miller MJ (2011). Lactobacillus adhesion to mucus. Nutrients. 3(5): 613-636.
  62. Thomas MS, Wigneshweraraj S (2014). Regulation of virulence gene expression. Virulence. 5(8): 832-834.
  63. Tien MT, Girardin SE, Regnault B, Bourhis L, Dillies MA, Coppee JY, Bourdet-Sicard R, Sansonetti PJ, Pédron T (2006).Antiinflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176: 1228–1237.
  64. Venkateshwari S, Halami PM, Vijayendra SVN (2010). Characterization of the heat stable bacteriocin producing and vancomycin-    sensitive Pediococcus pentosaceus CFR B19 isolated from beans. Benefic. Microbes. 1: 159–164.
  65. Vijayendra SVN, Rajashree K, Halami PM (2010). Characterization of a heat stable anti-listerial bacteriocin produced by vancomycin sensitive Enterococcus faecium isolated from idli batter. Indian J. Microbiol. 50: 243–246.
  66. Wehkamp J, Harder J, Wehkamp K, Wehkamp-Von MB, Schlee M, Enders C, Sonnenborn U, Nuding S, et al. (2004). NF-KappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: A novel effect of a probiotic bacterium. Infect. Immun. 72: 5750-5758.
  67. Wu Y, Zhu C, Chen Z, Chen Z, Zhang W, Ma X, Wang L, Yang X, Jiang Z (2016). Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells. Vet. Immunol. Immunopathol. 172: 55-63.
  68. Yan F, Polk DB (2006). Probiotics as a functional food in the treatment of diarrhea. Curr. Opin. Clin. Nutr. Metab. Care. 9(6): 717-721.
  69. Younghoon K, Kim SH, Whang KY, Oh S (2008). Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J Microbio Biotechnol. 18(7): 1278-85.
  70. Yu JY, He XL, Puthiyakunnon S, Peng L, Li Y, Wu LS, Peng WL, Zhang Y, Gao J, Zhang YY, et al. (2015). Mucin2 is Required for probiotic agents-mediated blocking effects on meningitic E. coli-Induced pathogenicities. J. Microbiol. Biotechnol. 25(10): 1751-1760.
  71. Zacharof MP, Lovitt RW (2012). Bacteriocins produced by lactic acid bacteria. Proceedings of Asia-Pacific Chemical, Biological and Environmental Engineering Society. 2: 50-56. 

Editorial Board

View all (0)